Featured News

Latiglutenase is a dual enzyme investigational product designed to break down gluten in the stomach. Learn more about the trial and what this means for celiac disease patients.

Ukko, a startup focused on eradicating food allergies, intolerances, and sensitivities, has reached a promising stage in its effort to develop a gluten specifically designed for people with celiac disease.

We are determined to use every resource at our disposal, including strategic funding of research and advocacy, to help discover and bring to the celiac disease patient community therapeutic alternatives to the gluten-free diet.

Little Northern Bakehouse announces its third year of sponsorship of the Celiac Disease Foundation to support the health and nutrition needs of the celiac community with their gluten-free and plant-based offerings.

The Celiac Disease Foundation is proud to announce its sponsorship of the April 17th University of Chicago’s Celiac Disease & The Continuum of Care Virtual CME Symposium.

9 Meters Biopharma, Inc., a clinical-stage company focused on rare and unmet needs in gastroenterology, announced their collaboration with the Celiac Disease Foundation to support clinical trial enrollment.

Mikey’s, maker of gluten-free hand-held pockets and baked goods reaffirms its support for the Celiac Disease Foundation and celiac community.

For the second consecutive year, the Celiac Disease Foundation hosted the Patient Education & Advocacy Summit.

The Celiac Disease Foundation recently published an article in Mediaplanet’s Autoimmune Diseases digital campaign.

The Celiac Disease Foundation is proud to have been involved by recruiting patients essential for this trial’s success.